Kiniksa Pharmaceuticals L... (KNSA)
undefined
undefined%
At close: undefined
20.20
-0.30%
After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Revenue 270.26M 220.18M 38.54M - - - - -
Cost of Revenue 56.52M 46.97M 9.10M 3.81M 3.28M 286.00K 28.00K 22.00K
Gross Profit 213.74M 173.21M 29.44M -3.81M -3.28M -286.00K -28.00K -22.00K
Operating Income -25.20M 7.37M -156.64M -157.36M -169.96M -108.16M -65.40M -24.00M
Interest Income 8.54M 1.25M 97.00K 1.13M 6.05M 4.72M 529.00K 65.00K
Pretax Income -16.65M 11.03M -156.54M -156.23M -163.91M -103.44M -64.87M -23.94M
Net Income 14.08M 183.36M -157.92M -161.38M -161.87M -103.23M -64.87M -23.97M
Selling & General & Admin 129.43M 97.95M 85.95M 45.32M 34.96M 21.56M 9.04M 6.56M
Research & Development 76.10M 65.49M 99.30M 112.04M 135.00M 86.60M 56.36M 17.44M
Other Expenses 33.41M 1.25M 835.00K - - - - -
Operating Expenses 238.93M 163.44M 186.08M 157.36M 169.96M 108.16M 65.40M 24.00M
Interest Expense - 1.25M - - - - - -
Selling & Marketing Expenses - - - - - - - -
Cost & Expenses 295.45M 210.41M 195.18M 157.36M 169.96M 108.16M 65.40M 24.00M
Income Tax -30.74M -172.34M 1.39M 5.15M -2.05M -214.00K 2.00K 36.00K
Shares Outstanding (Basic) 70.06M 69.38M 68.58M 61.84M 54.05M 29.55M 32.47M 32.47M
Shares Outstanding (Diluted) 71.92M 70.42M 68.58M 61.84M 54.05M 29.55M 32.47M 32.47M
EPS (Basic) 0.20 2.64 -2.3 -2.61 -2.99 -3.49 -2 -0.74
EPS (Diluted) 0.20 2.60 -2.3 -2.61 -2.99 -3.49 -2 -0.74
EBITDA -22.86M 9.77M -154.28M -152.42M -167.90M -107.87M -65.37M -23.98M
Depreciation & Amortization 2.34M 4.22M 4.09M 3.81M 3.28M 286.00K 28.00K 22.00K